DanaFarber Cancer Institute News

Nine North Andover residents were recently honored as Pacesetters for the 2011 Boston Marathon A® Jimmy Fund Walk presented by Hyundai.

The following was submitted by the Jimmy Fund: Burger King A guests can help fight childhood cancers from May 28 through July 1 by donating $1 to the Jimmy Fund through the A Chance for KidsA program at participating Burger KingA restaurants in six New England states.

For years, doctors had little to offer people with advanced melanoma skin cancer - cases diagnosed after the cancer has spread.

The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis.

The Dana-Farber Cancer Institute in Boston is working to make the experience more pleasant with the installation of hundreds of pieces of fine art.

The following is a press release from Burger King/The Jimmy Fund: Burger King guests can help fight childhood cancers from May 28 through July 1 by donating $1 to the Jimmy Fund through the A Chance for Kids program at participating Burger King restaurants in six New England states.

The Dana-Farber Cancer Institute in Boston is working to make the experience more pleasant with the installation of hundreds of pieces of fine art.

The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis.

Judy Dynan, of Norwood, and Sharon Valle, of Braintree, were recently honored in the Boston Globe's 2012 "Salute to Nurses," a special section published annually which celebrates dozens of outstanding men and women in nursing across Massachusetts.

Eighteen Dover residentsA were recently honored as Pacesetters for theA 2011 Boston MarathonA Jimmy Fund Walk.

3Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA.

Regorafenib, an inhibitor of multiple cancer-associated kinases, is active in patients with metastatic gastrointestinal stromal tumors who have failed to respond to imatinib and sunitinib, according to a study published online May 21 in the Journal of Clinical Oncology .

For decades, neurologists have known that a diet high in fat and extremely low in carbohydrates can reduce epileptic seizures that resist drug therapy.

BOLTON - Medfield resident Jimmie Hain was recognized by the Jimmy Fund during its Opening Day Golf event at the International Golf Club on May 8 in Bolton.

NEW YORK, LONDON & HAMILTON, Bermuda -- -- Celtic Pharmaceutical Holdings L.P. , a global private equity firm focused on late stage pharmaceutical assets, announces that it has completed a successful Phase I/II study of the investigational new drug Xerecept A in pediatric patients who are dependent on the steroid Decadron to treat peritumoral brain ... (more)

It is a testament to the stature of Lawrence + Memorial as an exceptional community hospital that it was able to reach a partnership deal with the Dana-Farber Cancer Institute to open a cancer treatment center in Waterford.

A collaborative expedition into the deep genetics of prostate cancer has uncovered a distinct subtype of the disease, one that appears to account for up to 15 percent of all cases, say researchers at Weill Cornell Medical College, the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute.

Lawrence + Memorial Hospital and the Dana-Farber Cancer Institute have reached an agreement to partner on a new $35 million cancer center scheduled to open in 2013 in Waterford.

A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society of Clinical Oncology , June 1-5, ... (more)

Michael J. Hassett, M.D., M.P.H., of the Dana-Farber Cancer Institute in Boston, and colleagues conducted a prospective study that assessed GEP testing and its association with subsequent chemotherapy use in 7,375 women diagnosed with HR-positive breast cancer from 2006 to 2008 at 17 cancer centers.